Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China.
Xiaolong QiJitao WangXinyu LiZhengyan WangYanna LiuHua YangXiaodan LiJindong ShiHuihua XiangTao LiuNorifumi KawadaHitoshi MaruyamaZicheng JiangFengmei WangTetsuo TakeharaDon C RockeyShiv Kumar Sarinnull nullPublished in: Hepatology international (2020)
The case series raise the possibility that decompensated cirrhosis may be a risk factor for a poor outcome in patients with COVID-19.